| Effective rate | 21 |
| Inflammatory lesion count | 11 |
| Non inflammatory lesion count(Comedo) | 8 |
| IGA(Investigator’s Global Assessment) | 4 |
| DLQI(Dermatologic Life Quality Index) | 3 |
| VISIA | 3 |
| Testosterone | 2 |
| Estiradiol | 2 |
| TNF-α(Tumor Necrosis Factor-Alpha) | 2 |
| CADI(Cardiff Acne Disability Index) | 2 |
| Recurrence rate | 2 |
| Satisfaction score | 2 |
| ASS(Acne Severity Score) | 2 |
| NRS(Numeric Rating Scale) | 1 |
| Skindex-29 | 1 |
| Cortisol | 1 |
| DHEA-S(Dehydroepiandrosterone Sulfate) | 1 |
| IgE(Immunoglobuline E) | 1 |
| Antioxidant capacity | 1 |
| Porphyrin | 1 |
| IL-1(Interulkin-1) | 1 |
| IL-8(Interulkin-1) | 1 |
| Keratin 16 | 1 |
| Serum toll-like receptor-2 | 1 |
| Skin hydration | 1 |
| Acne global severity score | 1 |
| Improvement scale | 1 |
| ASI(Anxiety Sensitivity Index) | 1 |
| Cook’s acne grading system | 1 |
| Resolution time | 1 |
| Diameter erythema | 1 |
| GAGS(Global Acne Grading System) | 1 |
| Burke and Cunliffe(Global assessment scale) | 1 |
| Adherence | 1 |
| KAGS(Korean Acne Grading System) | 1 |